Summit Therapeutics
SMMT
#1056
Rank
C$24.46 B
Marketcap
$31.41
Share price
-5.70%
Change (1 day)
1,146.55%
Change (1 year)

Summit Therapeutics (SMMT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$0.19 B

According to Summit Therapeutics 's latest financial reports the company's total liabilities are C$0.19 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Summit Therapeutics - Total liabilities on balance sheet (from 2020 to 2020)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$0.16 B-77.22%
2022-12-31C$0.72 B1815.31%
2021-12-31C$38.08 M29.58%
2020-12-31C$29.38 M
2019-01-31C$40.97 M-71.56%
2018-01-31C$0.14 B71.12%
2017-01-31C$84.19 M230.9%
2016-01-31C$25.44 M37.42%
2015-01-31C$18.51 M140.51%
2014-01-31C$7.69 M101.68%
2013-01-31C$3.81 M3.59%
2012-01-31C$3.68 M3.72%
2011-01-31C$3.55 M-59.77%
2010-01-31C$8.83 M-34.87%
2009-01-31C$13.55 M-55.24%
2008-01-31C$30.29 M106.9%
2007-01-31C$14.64 M189.97%
2006-01-31C$5.04 M514.43%
2005-01-31C$0.82 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$3.18 B 1,499.11%๐Ÿ‡บ๐Ÿ‡ธ USA
C$30.75 M-84.55%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.02 B 417.07%๐Ÿ‡บ๐Ÿ‡ธ USA